1. Volume 54, Issue 5, Pages 1073-1080 (November 2008)
PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging 
Stacy Loeb, Anna Kettermann, Luigi Ferrucci, Patricia Landis, E. Jeffrey Metter, H. Ballentine Carter 
European Urology 
Volume 54, Issue 5, Pages (November 2008)
DOI: /j.eururo
Copyright © 2008 European Association of Urology Terms and Conditions

2. Fig. 1 Selection criteria for the study population.
Abbreviations: PSA, prostate-specific antigen; pCA, prostate cancer; BPH, benign prostatic hyperplasia.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions

3. Fig. 2
Receiver operating characteristic analysis for the prediction of high-risk disease using (a) PSA and (b) PSAV and (c) for predicting the absence of high-risk disease using PSA DT.
Abbreviations: PSA, prostate-specific antigen; PSAV, prostate-specific antigen velocity; PSA DT, prostate-specific antigen doubling time; ROC, receiver operating characteristic.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions